"It's exciting the work that our teams have done together, something that we've always heard about, which is that you'll be able to predict response to therapy," said Dr. Matthew Callstrom.
"There's been a foundation model for language, there have been foundation models for protein folding, and the work Mayo has done on our equipment is a foundation model for genomics," said Cerebras co-founder and CEO Andrew Feldman.
The goal is to "build the ChatGPT of healthcare," according to Cerebras and Mayo Clinic, showcasing an ambitious shift in personalized medicine.
The potential capability to predict drug response from patients with rheumatoid arthritis could significantly accelerate diagnostic time and improve accuracy, say the companies.
Collection
[
|
...
]